ORIC Pharmaceuticals Inc.
ORIC | NASDAQ
$12.78
+$0.11 (+0.87%)
Sep 22, 2026, 9:33 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.56 | -4.41 | -4.69 | -2.62 | -7.10 | -10.07 |
PEG Ratio | 0.28 | 0.66 | 0.36 | -0.30 | 0.18 | -0.07 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.87 | 2.31 | 2.11 | 1.05 | 2.04 | 2.56 |
P/FCF Ratio | -6.30 | -4.94 | -5.47 | -3.02 | -9.22 | -16.17 |
P/OCF Ratio | -6.33 | -4.99 | -5.52 | -3.11 | -9.37 | -16.41 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.01 | 0.05 | 0.05 | 0.01 | n/a |
Quick Ratio | 14.13 | 10.56 | 10.39 | 13.68 | 15.87 | 32.96 |
Current Ratio | 14.13 | 10.56 | 10.39 | 13.68 | 15.87 | 32.96 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -34.69 | n/a | n/a |
Return on Equity | -33.68% | -52.59% | -44.94% | -40.08% | -28.84% | -25.43% |
Return on Assets | -31.50% | -46.64% | -39.54% | -35.60% | -26.36% | -24.65% |
Return on Invested Capital | -36.30% | -56.60% | -46.75% | -38.62% | -27.63% | -25.58% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ORIC